Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A peptide to DOG1/TMEM16A. Accession #: Q5XXA6.
Synthetic
The DOG1/TMEM16A Blocking Peptide is derived from Synthetic. The DOG1/TMEM16A Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-081041 |
| Réf. fabricant | 18186232 |
| Gene ID (Entrez) | 55107 |
| Espèces | Human |
| Pureté | >85% |
| Contenu et stockage | Store at 4 C short term. Aliquot and store (at -20 C long term. Avoid freeze-thaw cycles.) |
| Formule | PBS, BSA 0,1 % |
| À utiliser avec (application) | This Peptide is Useful as a Blocking Peptide for NBP2-29662. This Peptide Blocks Completely The Immuno Reactivity of The Antibody NBP2-29662 in. Western Blot or Immunohistochemistry by Incubating The Peptide with Equivalent Volume of Antibody for 30 Min (at 37 Degrees C. For Further Blocking Peptide Related Protocol, Click Here .) |
| Alias de gène | ANO1, anoctamin 1, DOG1, ORAOV2, TAOS2, TMEM16A |
| Symbole de gène(s) | ANO1 |
| Poids moléculaire | M.W. (theoretical): 0.81 kDa |
| Type de produit | DOG1/TMEM16A |
| Quantité | 0.05 mg |
| État réglementaire | RUO - research use only |
